Cited by 51Birth, Development, and HealthGestational Diabetes Research and ManagementPregnancy and preeclampsia studies

Obesity and Pregnancy, the Perfect Metabolic Storm

Open access
Corrales, Patricia, Vidal-Puig, Antonio, Medina-Gómez, Gema·2021·European Journal of Clinical Nutrition

Abstract

Pregnancy is a physiological stress that requires dynamic, regulated changes affecting maternal and fetal adiposity. Excessive accumulation of dysfunctional adipose tissue defined by metabolic and molecular alterations cause severe health consequences for mother and fetus. When subjected to sustained overnutrition, the cellular and lipid composition of the adipose tissue changes predisposing to insulin resistance, diabetes, and other metabolic disorders compromising the outcome of the pregnancy. Moreover, excessive maternal weight gain, usually in the context of obesity, predisposes to an increased flux of nutrients from mother to fetus throughout the placenta. The fetus of an obese mother will accumulate more adiposity and may increase the risk of future metabolic disorder later in life. Thus, further understanding of the interaction between maternal metabolism, epigenetic regulation of the adipose tissue, and their transgenerational transfer are required to mitigate the adverse health outcomes for the mother and the fetus associated with maternal obesity.

Integrity signals

Registry

Crossref · 10.1038/s41430-021-00914-5

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The risk of GDM is 6.5 times higher in pregnancies complicated by obesity, hypertension, and preeclampsia than in normal-weight pregnancies.

    “For the mother, obesity is a risk factor for GDM: the risk of GDM is 6.5 times higher in pregnancies complicated by obesity, hypertension, and preeclampsia than in normal-weight pregnancies.”
  • In obese pregnancies, uncontrolled placental inflammation compromises placental function, increasing fatty acids in fetal circulation and fetal hyperinsulinemia.

    “As a result, there is uncontrolled placental inflammation that compromises placental function, increasing fatty acids (FAs) in the fetal circulation; furthermore, in mothers with obesity, high glucose levels are exposed as a nuoktrient to the fetus, and this excess of nutrients from maternal glucose stimulates fetal hyperinsulinemia during gestation.”
  • In obese pregnant women, excess adiposity leads to increased insulin resistance, altered lipid metabolism, and inflammation, increasing nutrient flux from mother to fetus and promoting placental changes.

    “In obese pregnant women, normal physiology is disrupted by excess adiposity, which leads to increased insulin resistance, altered lipid metabolism, and inflammation. This disruption increases the nutrient flux from mother to fetus and promotes changes in the placenta.”
  • Offspring of obese mothers have increased risk of adverse neonatal outcomes such as preterm birth, large for gestational age, macrosomia, impaired fetal growth, and hypoglycemia, as well as long-term obesity and metabolic dysfunction.

    “Offspring also have an increased risk of adverse neonatal outcomes such as preterm birth, being large for gestational age, macrosomia, impaired fetal growth, and hypoglycemia, as well as a long-term risk of developing obesity and metabolic dysfunction [25,26].”
  • Excessive gestational weight gain increases the risk of postpartum weight maintenance, stabilizing obesity and promoting cardiometabolic complications including T2D and CVDs in later life.

    “Moreover, the accumulation of excessive gestational weight also increases the risk of postpartum weight maintenance, stabilizing obesity and promoting obesity-associated cardiometabolic complications, including T2D and CVDs in later life.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Corrales, P., Vidal-Puig, A., & Medina-Gómez, G.
Affiliations
Universidad Rey Juan Carlos (ES)
Corresponding author
Corrales, Patricia
Venue
European Journal of Clinical Nutrition
Published
2021-04-28
Volume
75
Issue
12
Pages
1723-1734
ISSN
  • 0954-3007 (ISSN-L)
  • 1476-5640
OpenAlex
W3159278622
Cited by
51
References
13
Citations by year
2026: 7 · 2025: 9 · 2024: 17 · 2023: 6 · 2022: 9 · 2021: 3
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • European Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
MRC
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
maternal obesity, pregnancy, adipose tissue dysfunction, insulin resistance, gestational diabetes mellitus, gestational weight gain, placental nutrient transfer, fetal adiposity, epigenetic regulation, overnutrition
MeSH terms
Female, Humans, Insulin Resistance, Obesity, Placenta, Pregnancy, Pregnancy Complications, Epigenesis, Genetic, Overnutrition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review